CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [ *** ] INDICATES THAT INFORMATION HAS BEEN OMITTED. Execution Version FIRST AMENDMENT...Note Purchase Agreement • November 8th, 2023 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 8th, 2023 Company Industry Jurisdiction